| Dr Charles A Peter, MD | |
|
1 Park West Blvd, Ste 150, Akron, OH 44320 | |
| (330) 864-8060 | |
| (330) 864-8074 |
| Full Name | Dr Charles A Peter |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1 Park West Blvd, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922027085 | NPI | - | NPPES |
| 000000126054 | Other | ANTHEM | |
| 0153211 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 35029917 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles A Peter, MD 1 Park West Blvd, Ste 150, Akron, OH 44320 Ph: (330) 864-8060 | Dr Charles A Peter, MD 1 Park West Blvd, Ste 150, Akron, OH 44320 Ph: (330) 864-8060 |
News Archive
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight threatening eye diseases, today announced that a phase 2b/3 clinical trial investigating emixustat hydrochloride in subjects with geographic atrophy associated with dry age-related macular degeneration has been initiated.
Delaying school start times could help Canadian teenagers sleep better - giving them a better chance for success, according to McGill University researchers.
New ultrasmall peptides that can be used as building blocks for a wide range of regenerative applications such as spinal disc replacement and cartilage repair have been developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute. These peptides spontaneously assemble in water to form hydrogels, which resemble collagen, a major component of connective tissues found in cartilage, ligaments, tendons, bone and skin.
A nanoparticle that can destroy drug-resistant bacteria developed by the Institute of Bioengineering and Nanotechnology (IBN), and the IBM Almaden Research Center, has recently been named one of 10 world changing ideas by Scientific American in its Technology Special Report ('World Changing Ideas – 10 New Technologies That Will Make a Difference', December 2011).
› Verified 1 days ago
Dr. Richard R Ellison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Dr. Nancy N Hanna, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 | |
Dr. Cetin Akpolat, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 215 W Bowery St Fl 2, Akron, OH 44308 Phone: 330-543-5290 | |
Dr. David G Burket, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Dr. William R Yeakley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Mary P File, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 444 N Main St, Akron, OH 44310 Phone: 330-253-1140 Fax: 330-315-6408 | |
Dr. Ian Pacey Boydstun, D.O. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 |